VIP in inflammatory bowel disease: state of the art.
Abad C, Gomariz R, Waschek J, Leceta J, Martinez C, Juarranz Y, Arranz A.
Abad C, et al. Among authors: waschek j.
Endocr Metab Immune Disord Drug Targets. 2012 Dec;12(4):316-22. doi: 10.2174/187153012803832576.
Endocr Metab Immune Disord Drug Targets. 2012.
PMID: 23094828
Review.